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Abstract
Egress of vaccinia virus from its host cell is mediated by the microtubule-associated motor kinesin-1, and three viral
proteins, A36 and the F12/E2 complex, have been implicated in this process. Deletion of F12 expression causes a more
severe reduction in egress than deletion of A36 but whether these proteins are involved in the same or different
mechanisms of kinesin-1 recruitment is unknown. Here it is shown that a virus lacking both proteins forms a smaller plaque
than mutants lacking either gene alone, indicating non-redundant functions. A36 not only links virions directly to kinesin-1
but also nucleates actin polymerization to propel surface virions away from the host cell. To address the relative importance
of these functions for virus spread, a panel of recombinant viruses was constructed in which the ability of A36 to bind
kinesin-1 or to nucleate actin polymerization was abrogated individually or together, in the presence or absence of F12
expression. Analysis of these viruses revealed that in the presence of the F12 protein, loss of kinesin-1 interaction made a
greater contribution to plaque size than did the formation of actin tails. However in the absence of F12, the ability of A36 to
promote egress was abrogated. Therefore, the ability of A36 to promote egress by kinesin-1 is reliant on the F12 protein.
INTRODUCTION
Vaccinia virus (VACV) is the prototypic member of the Pox-
viridae, a family of large, complex DNA viruses that replicate
in the cytoplasm of host cells [1] and includes variola virus,
the causative agent of smallpox [2]. VACV is a valuable
model to study cytoskeleton-mediated trafficking because it
hijacks both the microtubule (MT) and actin networks to
facilitate virus transport within and between cells [3, 4].
Upon entry into a cell, VACV cores migrate into the cell inte-
rior in an MT-dependent manner [5] to form virus factories
where new virions are assembled [6]. The first infectious viri-
ons formed are intracellular mature virus (IMV) or mature
virus (MV) [7]. Some IMVs migrate away from viral factories
in an MT-dependent process [8] and become wrapped by a
double layer of early endosomal [9] or trans-Golgi [10] mem-
branes, to form intracellular enveloped virus (IEV), also
called wrapped virus (WV). IEVs are in turn transported
towards the cell surface in an MT-dependent process [11–14]
where their outer envelope fuses with the cell membrane,
exposing the virion on the cell surface. Virions that remain
attached to the host cell are known as cell-associated envel-
oped virus (CEV) and can induce a transmembrane signal
that stimulates actin polymerization, resulting in formation of
an actin tail propelling the virion away from the cell
(reviewed in [3, 15]). Released virions are called extracellular
enveloped virus (EEV) (reviewed in Roberts and Smith [4]).
These virions mediate long range spread of virus in cell cul-
ture and in vivo [16], and are resistant to complement due to
incorporation of host complement control proteins into the
EEV envelope [17].
During IEV formation, virions acquire a double envelope
containing at least five virus integral membrane proteins: B5
[18, 19], A33 [20], A34 [21], A36 [22, 23] and A56 [24]. In
addition, protein F13 is attached to the membrane via acyl-
ated cysteine residues [25], and proteins F12 [26] and E2
[27] are indirectly and transiently associated with the IEV
particle during egress [28]. All of these proteins, except A56,
interact with at least one other member of this group [29]
and are involved in the formation and/or egress of IEVs
[30]. Of these, A36 [22, 31], F12 [26, 32] and E2 [27, 33] are
involved in MT-mediated IEV egress.
IEV egress is mediated by kinesin-1 [14], also known as
conventional kinesin, the prototype member of the kinesin
protein superfamily [34]. Kinesin-1 is a tetrameric complex
consisting of two copies of the kinesin heavy chain (KHC)
and two copies of the kinesin light chain (KLC). A36 pos-
sesses two copies of a WE/D motif (a tryptophan residue
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followed by either a glutamic acid or aspartic acid residue)
that form a bipartite kinesin-1 interaction motif [33] also
found in cellular kinesin-interacting proteins [35, 36]. Pepti-
des containing this WE/D motif interact with a binding
groove formed by the tetratricopeptide repeat (TPR) cargo
interaction region of KLC [37].
Unlike most of the other IEV envelope proteins, A36 is associ-
ated predominantly with the outer IEV envelope and after
virion release it accumulates on the plasma membrane
beneath CEVs [23]. Phosphorylation at tyrosine 112 and 132
by Src and Abl family kinases results in recruitment of Nck,
Grb2, Cdc42, N-WASP and WIP, to nucleate actin polymeri-
zation via the Arp2/3 complex [38, 39], producing actin tails.
A36 and A33 expressed early during virus replication form a
complex on the cell surface and induce actin tails beneath
superinfecting CEV/EEV virions that repel the virions away
from the cell and enhance virus spread [40, 41].
F12 associates with IEVs in an A36-dependent manner [42],
and indirectly with KLC via its binding partner E2 [43].
While both A36 and F12 have been implicated in IEV
egress, and viruses lacking expression of either protein are
severely attenuated in vivo [22, 26], their relative impor-
tance for IEV egress is different. Viruses lacking F12 expres-
sion show a more severe reduction in egress [26] than
viruses lacking A36 expression [44]. It is unclear if A36 and
F12 contribute to IEV egress together via the same process
or independently via separate processes. The ability of IEVs
to move at MT-dependent trafficking speeds in the absence
of A36 [44] and the reported movement of IEVs in the
absence of F12 [28] would suggest that two independent
processes are involved.
To address this issue, a mutant virus was constructed lack-
ing both proteins. This virus formed smaller plaques than
viruses lacking either A36 or F12 alone. To determine the
contribution of A36-mediated actin tail formation and A36-
mediated kinesin-1 recruitment to this phenotype, a panel
of viruses was constructed in which A36 was mutated to
lose either or both of these properties. These mutations
were introduced into viruses that do or do not express F12.
Analysis of these viruses revealed that in the presence of F12
both properties of A36 contributed to spread. However, in
the absence of F12, even when A36 retained the WE/D
motifs required for interaction with KLC, A36 was unable
to contribute to IEV egress.
RESULTS
Deletion of A36 and F12 has a cumulative effect on
virus spread but not on IEV egress
Recombinant VACVs expressing GFP fused to the A5 cap-
sid protein have been constructed in a wild-type (WT) back-
ground [5] and in viruses lacking either A36 (vDA36) or
F12 (vDF12) expression [44]. To test if mutations in A36
and F12 have a cumulative effect on IEV egress or VACV
spread, a virus lacking both genes, vDA36DF12 or vDD, was
constructed. The parent virus used was vDA36 A5-GFP and
the F12L gene was disrupted by transient dominant selec-
tion (see Methods). During this process an intermediate
virus is formed that contains the WT F12L gene and the
deleted version. This unstable intermediate then resolves to
either mutant or parental virus, which can be distinguished
by PCR. Resolution of the intermediate virus gave two sizes
of plaque and PCR analysis showed that all the larger pla-
ques represented the vDA36 A5-GFP parent, while all the
smaller plaques were vDA36DF12. Single clones of a large
(parental virus referred to as the sibling) and small plaque
representing vDA36DF12 were plaque purified, amplified
and their genotypes were analysed by PCR and confirmed
to be as expected (Fig. 1a).
Plaque size analysis on BS-C-1 cells showed that both
vDA36 and vDF12 produced plaques considerably smaller
than WT virus with those formed by vDF12 being signifi-
cantly smaller than vDA36 (Fig. 1b, c), as noted previously
[45]. In comparison, vDA36DF12 produced plaques signifi-
cantly smaller than vDA36 and even smaller than vDF12
(Fig. 1b, c). As expected, the vDA36 sibling produced
plaques indistinguishable from the parental vDA36.
Plaque size can be affected by several factors including virus
replication, egress, spread to new cells and blocking the host
response to infection. To address if virus replication was
altered, the yields of infectious intracellular virus were mea-
sured and showed no significant difference between the
viruses (Fig. 1d). Next the egress of virus to the cell surface
was measured by flow cytometry as previously described
[43]. Unpermeabilized HeLa or U-2 OS cells were stained
with an antibody to B5 to detect surface CEVs and then
analysed by flow cytometry (Fig. 1e). Surface B5 levels were
reduced in vDA36-infected cells compared to WT virus
infection and were reduced further in vDF12-infected cells.
There was no detectable difference in surface B5 staining
between vDA36DF12 and vDF12.
These results indicate that while deleting both F12 and A36
had a cumulative detrimental effect on virus spread, this
was not due to a reduction in replication. The reduced effi-
ciency of spread of vDA36DF12 compared to vDF12 was not
a result of a reduction in virus transport to the cell surface.
Therefore, it seems that the loss of the A36 protein is
important for egress only if F12 is present and makes little
difference if F12 is absent.
A36 contributes to VACV spread by two separate mecha-
nisms. It links the IEV particle to kinesin-1 and it induces
actin tail formation from the cell surface. Viruses lacking
A36 have reduced virus egress and are unable to enhance
spread by producing actin tails. Viruses lacking F12
show >99% loss of IEV egress; however, the few virions that
reach the cell surface can induce actin tail formation. There-
fore, it is possible that the reason vDF12 produces larger
plaques than vDA36DF12 is the ability to produce a few
actin tails. Alternatively, the difference may be due to small
changes in egress caused by loss of A36 that were not
detected by the egress assay shown in Fig. 1(e). To
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distinguish between these alternatives, additional viruses
were constructed in which A36 was mutated to remove its
ability to interact with kinesin, or to induce actin tail forma-
tion, or both activities. These mutations were introduced
into viruses that did or did not express the F12 protein.
Analysis of viruses with mutations in A36
The interaction of A36 with kinesin can be abrogated by
mutating the two WE/D motifs found at positions 64 (WE)
and 97 (WD) to alanines [35]. Similarly, the ability of A36
to induce actin tail formation can be abrogated by mutating
tyrosines 102 and 132 to phenylalanine [46]. Recombinant
viruses were generated by re-introducing either WT or
mutant A36 alleles into DA36. Re-introduction of WT A36
generated a revertant virus referred to as rev. Insertion of
A36 incorporating the 64WE and 97WD into alanine muta-
tions formed a virus named WEWD. Insertion of A36 bear-
ing the Y102F and Y132F mutations formed a virus called
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Fig. 1. Deleting both A36 and F12 expression from VACV has a cumulative detrimental effect on spread but not egress. (a) PCR analy-
sis of recombinant virus genomes to confirm the deletion of the F12 locus in the double deletion virus vDA36DF12-A5GFP. PCR frag-
ments were generated using primers flanking the deleted region with an ~2 kb band indicating presence of the WT allele and a 500bp
band indicating the DF12 allele. Analysis of the intermediate virus possessing both alleles is included. (b) Plaque size comparison of
vA5GFP (WT), vDA36-A5GFP (DA36), vDF12-A5GFP (DF12) and the newly generated vDA36DF12-A5GFP (DA36DF12) and its sibling
(sib). Monolayers of BS-C-1 cells were infected with about 30 p.f.u. per well and stained 7 days post-infection (p.i.). A single 35mm
diameter well (top) is shown as well as a single plaque (bottom, scale bar represents 500µm). (c) Quantification of plaque size analy-
sis. The mean plaque diameter was calculated from measurements taken from a minimum of 45 individual plaques from three inde-
pendently-infected wells (~15measurements per well). Statistical significance calculated by Student’s t-test. ****, P<0.0001. (d)
Analysis of virus replication. Viruses were used to infect a monolayer of BS-C-1 cells in a 35mm diameter dish at 10 p.f.u. per cell.
Virus-infected cells were harvested 24 h later and total infectious virus present in the medium and cells was titrated by plaque assay.
Values represent means from three independent samples. None of the samples showed a statistically significant difference in titres
when compared to the WT sample by Student’s t-test, or when all the means were compared by one-way ANOVA. (e) Measurement of
cell surface virus by flow cytometry. HeLa or U-2 OS cells were infected at 5 p.f.u. per cell and stained for surface B5 prior to fixation
and analysis by flow cytometry. Mean fluorescence intensity (MFI) per cell is shown as the mean (in arbitrary units, AU) of three inde-
pendently-infected samples (>2000 events analysed per sample). Statistical significance calculated by Student’s t-test as indicated (***,
P<0.001; **, P<0.01; *, P<0.05; NS, not significant).
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Fig. 2. Construction and verification of a panel of viruses in which the two functions of A36 have been mutated individually. (a) Sche-
matic representation of the A36 protein showing the localization of its transmembrane domain (TM), kinesin-interacting WE/D motifs
(green) and tyrosines involved in nucleating actin polymerization (red). A panel of viruses was constructed by re-introducing full-length
A36 into viruses in which a region of A36 had been deleted (shown in grey) to produce viruses with a WT A36 sequence (rev), with
both WE/D motifs in A36 mutated to alanines (WEWD), with the actin nucleation tyrosines mutated to phenylalanine (YdF), or with both
of these mutations to produce a double mutant (dm). Coloured arrows show position of primers used for PCR identification of
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YdF, and insertion of A36 bearing both WEWD and YdF
mutations produced a virus called double mutant or dm
(Fig. 2a). One set of viruses was generated using vDA36-
A5GFP as the parental strain and another set was generated
using vDA36DF12-A5GFP, described above, to generate the
same panel of A36 mutants in a background lacking F12
expression. Both recombinant and parental sibling clones
were plaque purified for each of the mutant viruses. Clonal
identity and purity were verified by PCR (Fig. 2b) and
sequence analysis of the A36 locus.
Immunoblot analysis of A36 expressed by the various
recombinant viruses showed that there were some changes
in electrophoretic mobility on SDS-PAGE and in particular
the dm A36 protein had several different forms (Fig. 2c).
Interestingly, the banding pattern of A36 was altered by the
presence or absence of F12. The ability of these mutant A36
proteins to interact with KLC was examined by immuno-
precipitation. Cells were transfected with Flag-tagged KLC
(isoform 1) and then infected with the different viruses. As
expected, viruses expressing A36 with intact WE/D motifs
(rev and YdF mutants) co-immunoprecipitated with KLC1,
while those in which the WE/D motifs had been mutated
(WEWD and dm) did not (Fig. 2d).
A36-mediated kinesin-1 recruitment can contribute
to virus egress only in the presence of F12
To analyse the contribution of each of the functions of A36
to virus spread, the plaque size of each mutant virus was
analysed on BS-C-1 cells and compared to viruses lacking
F12, or A36, or both proteins (Fig. 3). Re-introduction of
WT A36 into vDA36 rescued the plaque size to WT, while
all the mutant A36-expressing viruses produced plaque sizes
smaller than WT. The YdF virus produced plaques almost
half the area of WT plaques and the WEWD virus plaques
were about a quarter the area of WT. If kinesin-1 binding
and actin nucleation are the only functions of A36 then
knocking both of these out should result in a plaque size
similar to vDA36. Instead the dm virus produced plaques
even smaller than vDA36, suggesting that the presence of
the dm A36 can interfere with virus spread. The observation
that both YdF and WEWD mutants produced larger
plaques than dm or vDA36 indicated that, in a WT back-
ground, both kinesin-1 interaction and actin polymerization
contribute to virus spread.
The contribution of these mutant A36 proteins was studied
next in the DF12 background (Fig. 4). Re-introducing WT
A36 rescued the plaque size back to that of vDF12. However,
of the mutant A36 alleles, only the WEWD virus rescued
plaque size at all, and only to about one-fifth of the area of
plaques produced by vDF12 rev. Notably, unlike in the WT
background expressing F12, in the absence of F12 the YdF
A36 mutant was unable to rescue plaque size. In fact, both
YdF and dm viruses produced plaques smaller than the
vDA36DF12 parent or sibling viruses. These results indi-
cated that in the absence of F12, the ability of A36 to inter-
act with kinesin-1 is unable to contribute to viral spread.
To measure the efficiency of egress of the different mutant
viruses, the egress assay described above (Fig. 1e) was used
again (Fig. 5). In this case, egress was not only measured by
flow cytometry (measuring the total cell surface B5 levels,
Fig. 5a), but also by immunofluorescencemicroscopy to quan-
tify B5-positive GFP puncta (virions) on the cell surface
(Fig. 5b) giving a direct measurement of the number of virions
that reach the cell surface (described inMethods and in [44]).
The YdF mutation should theoretically have no effect on
egress compared to the rev virus; however, both assays show
a small drop in the level of cell surface virions. Likewise the
WEWD mutant would be expected to reduce egress to the
level of vDA36. Instead, it seems to reduce egress slightly
further. The levels of egress of the WEWD and dm mutant
viruses were indistinguishable in both assays, indicating that
the plaque size difference shown in Fig. 3 is attributable to
the ability of WEWD to form actin tails. However, for the
viruses made in the DF12 background it did not matter
what version of A36 was present. The levels of egress by
vDF12 and vDA36DF12 were indistinguishable. Therefore,
in the absence of F12, the ability of A36 to engage kinesin-1
is unable to contribute to egress.
As a side note, in the egress assays a sample was included as
a negative control in which cells infected with vA5GFP were
recombinant viruses (see Methods). (b) PCR analysis of recombinant virus genomes. WT and mutant A36 genes were introduced into
vDA36-A5GFP as the parent (left panel) or vDA36DF12 (right panel). The presence of a full-length A36 allele in the recombinant
viruses was confirmed using primers represented by the red and blue arrows in Fig. 2(a). No full-length A36 was detected in any of
the isolated sibling viruses. Primers flanking the region deleted in DA36 viruses, represented by the green and blue arrows in Fig. 2
(a), only detected the predicted genomes in the recombinant viruses. A PCR using primers specific for the EcoGPT selection cassette
present in intermediate viruses did not detect this cassette in any of the purified virus stocks. A PCR that could distinguish between a
full length F12L ORF and a deletion mutant was used to confirm the absence of any cross-contamination between the different
recombinants. The identity of the mutant A36 alleles was also confirmed by sequence analysis. (c) A36 expression analysis by SDS-
PAGE and immunoblotting. Monolayers of BS-C-1 cells were infected with the indicated viruses at 10 p.f.u. per cell. Lysates were har-
vested 16 h p.i., normalized by total protein concentration and analysed by immunoblotting. An antibody to the VACV D8 IMV surface
protein was used as a loading control. The positions of molecular mass markers are shown (kDa). The image shown is representative
of three experiments. (d) Co-immunoprecipitation analysis of A36/KLC interaction. HEK293T cells were transfected with a plasmid
expressing Flag-KLC1 (or Flag-GFP as a negative control) and infected with the indicated viruses at 5 p.f.u. per cell for 14 h. Cell
lysates were prepared and used for immunoprecipitation with anti-Flag beads (aFlag-IP). Input lysates (top) and immunoprecipitated
proteins (bottom) were analysed by SDS-PAGE and immunoblotting. The positions of molecular mass markers are shown (kDa). The
image shown is representative of two independent experiments.
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treated with the drug IMCBH (N1-isonicotinoyl-N2-3-
methyl-4-chlorobenzoylhydrazine), an inhibitor of poxvirus
spread that binds the F13 protein and interferes with the
wrapping of IMV to form IEV [47, 48]. In the presence of
IMCBH, the lack of IEV formation should result in a loss of
virus egress. However in the flow cytometry assay, IMCBH-
treated cells showed high levels of surface B5 staining
(Fig. 5a) suggesting egress was taking place. When the assay
was repeated by immunofluorescence, IMCBH-treated cells
were found to have high levels of surface B5 staining
(Fig. 5a, c) but practically none of this surface B5 co-local-
ized with virion GFP signal (Fig. 5b, c). Lastly, immunofluo-
rescence confocal microscopy of infected BS-C-1 cells was
used to assess the subcellular distribution of the A36 mutant
proteins and their ability to induce actin tail formation
(Figs 6 and 7). A36 accumulates at a perinuclear site repre-
senting the site of IMV wrapping which is near to, but sepa-
rate from, virus factories. All of the mutant A36 proteins
showed this localization whether F12 was present (Fig. 6) or
absent (Fig. 7). A36 proteins capable of binding kinesin-1,
in the presence of F12, showed secondary accumulation at
the cell periphery (Fig. 6a) co-localizing with virions
[Fig. 6b(i), b(ii)]. However, when A36-mediated recruit-
ment of kinesin-1 was abrogated, either because A36 was
absent, or because the WE/D motifs were mutated, virions
did not localize to the cell periphery and instead accumu-
lated at the site of wrapping (Fig. 6a). In the absence of F12,
this accumulation was evident for both WT and all mutant
versions of A36 (Fig. 7). In the presence of F12, actin tails
were present when WT A36 was expressed but absent for
the YdF and dm mutants lacking the actin nucleation motifs
[Fig. 6b(iii), b(iv)]. Actin tails were more difficult to find for
the WEWD mutant than for the rev virus, reflecting the
reduction in virus egress. When actin tails were present they
often formed, not at the cell periphery, but at the apical or
basal cell surface nearer to the cell nucleus and the site of
wrapping [Fig. 6b(ii)].
DISCUSSION
In the absence of A36, IEVs are still transported on MTs
but the run length is reduced and, although there is a delay
in their transport, surface virions reach 50% of WT level by
24 h post-infection [44]. In the absence of F12, there is a
much more severe reduction in egress to the cell periphery
and surface virions represent less than 1% of WT levels [26,
44]. This is surprising given that A36 links IEVs directly to
kinesin [31] and is required for F12 to associate with IEVs
[42]. To analyse the relative contributions of A36 and F12, a
virus defective in the expression of both proteins was con-
structed. As would be expected if A36 and F12 mediated
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Fig. 3. Plaque size comparison of viruses expressing F12. (a) Plaque
size comparison of the indicated recombinant viruses 3 days p.i.
Images of single representative plaques are shown; bar, 500µm. (b)
Quantitative analysis of plaque sizes. A minimum of 15 plaques from
three independent infections were measured (total of 45 plaques).
Graph shows mean plaque area ±SD. Mutant A36-expressing viruses
were compared statistically to the WT A36-expressing rev virus and/
or to their sibling virus as indicated using Student’s t-test (****,
P<0.0001; **, P<0.01).
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egress by different pathways, this virus produced plaques
smaller than viruses lacking A36 or F12 expression individ-
ually. However, the contribution of A36-mediated actin tail
formation to virus spread, and consequently to plaque size,
complicated interpretation of this observation. Additionally,
actin tails enhance the rate of virus spread by repelling
superinfecting virions [40]. Measuring the level of virion
egress by staining surface virions with antibody to B5 sug-
gested there was no difference in egress efficiency between
vDA36DF12 and vDF12. Actin tails can also enhance virion
release from the cell surface into the extracellular medium
[49]. This has the potential to skew or mask any differences
in surface virions when comparing a virus lacking actin tails
with one that can produce actin tails.
By constructing a panel of viruses in which A36-mediated
actin polymerization was abrogated, either alone or in con-
cert with disruption of the A36/KLC interaction, the con-
founding factor of actin tails was eliminated. Comparison of
viruses expressing A36 capable of KLC recruitment with
viruses expressing A36 unable to bind KLC (comparing YdF
to dm) revealed that, in the presence of F12, A36 kinesin-1
recruitment resulted in increased egress. In contrast, in the
absence of F12 it does not (see Fig. 8 for a summary of the
phenotypes of all the viruses analysed). A36-mediated egress
is thus completely reliant on F12. It has been reported that
F12 is required for IEV formation rather than egress [28].
However, electron microscopy evidence of fully formed
IEVs in the absence of F12 and the observation that IEVs
are more abundant in infections with viruses lacking F12
than during WT VACV infection [33] refute this. Similarly,
loss of A36 does not affect IEV formation [50, 51]. There-
fore, plaque size reduction and reduced virus egress result-
ing from disruption of either F12 or A36 are due to defects
downstream of IEV formation.
Unlike F12 and A36, F13 is required for IEV wrapping
and this is inhibited by IMCBH [47, 48]. Therefore,
IMCBH was used to measure baseline B5 levels when
wrapping and, consequently, egress are inhibited. This
showed that, while surface virions are virtually absent
after IMCBH treatment, B5 is present on the cell surface.
This is reminiscent of the recent observations made by
Sivan et al. [52] when cellular retrograde trafficking was
disrupted. F13 and B5 are both required for IEV wrapping
[53] and both localize to the membranes that form the
IEV envelopes. However, these proteins take alternative
routes to reach the membranes at the site of wrapping
[52]. There is some evidence that B5 reaching the plasma
membrane is re-internalized by endocytosis [54] similar
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Fig. 4. Plaque size comparison of viruses in the absence of F12
expression. (a) Plaque size comparison of indicated viruses 9 days p.i.
Images of single representative plaques are shown; bar, 500 µm.
Higher magnification images are provided for the smallest plaques
(inserts) with a scale bar of 200 µm. (b) Quantitative analysis of plaque
sizes. A minimum of 45 plaques from three independent infections
were measured. Graph shows mean area ±SD. Mutant A36-expressing
viruses were compared statistically to the WT A36-expressing rev
virus and/or to their sibling virus as indicated using Student’s t-test
(****, P<0.0001; ***, P<0.001; *, P<0.05).
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to the mechanism by which herpes simplex virus glyco-
proteins are transported to the membranes used to form
the virion envelope [55]. It is unclear whether the
presence of IMCBH enhances B5 transport to the cell sur-
face, or if B5 recycling by endocytosis is somehow inhib-
ited by IMCBH.
Phase A5GFP Surface B5 DAPI
vA
5
G
F
P
−
IM
C
B
H
+
IM
C
B
H
Flow cytometry Immunofluorescence
M
F
I s
u
rf
ac
e
 B
5
 s
ta
in
in
g
 (
A
U
)
S
u
rf
ac
e
 v
ir
io
n
s 
c
e
ll–
1
∆F
12
∆ F
12
 re
v
∆A
36
∆F
12∆A
36
∆F
12
 W
EW
D
∆F
12
 Y
dF
d∆
F1
2 
dm
IM
C
BHW
T
M
oc
k iso ∆B
5
Yd
F
re
v
dm
W
EW
D
∆F
12
∆ F
12
 re
v
∆A
36
∆F
12∆A
36
∆F
12
W
EW
D
∆F
12
Yd
F
∆F
12
dm
IM
C
BHW
T
Yd
F
re
v
dm
W
EW
D
20 000
15 000
10 000
5000
0 0
5
10
15
100
200
300
400
500
25
20
NS
NS
(a)
(c)
(b)
Fig. 5. Quantitation of IEV egress. Virion egress was measured by live cell surface staining of protein B5. Levels of staining were
quantified by two alternate methods. (a) Flow cytometric quantitation of infected cells surface stained for B5 and fixed at 12 h p.i. The
graph shows the mean measurements of three independently-infected samples. Values represent the mean fluorescence intensity
(MFI), given in arbitrary units (AU) per cell, of a minimum of 2000 events per replicate. Error bars represent standard error of the
mean (SEM). Cells infected with WT virus but stained with an isotype control antibody (iso), and cells infected with vDB5 but stained
with an anti-B5 antibody are included as controls. Infection with WT virus in the presence of a drug that inhibits IEV wrapping (IMCBH)
is also included. Results shown are representative of three independent experiments. (b) Surface virion quantitation by immunofluores-
cence confocal microscopy of cells infected with the recombinant viruses and stained for surface B5 at 8 h p.i. Confocal z-stacks of
the entire cell volume were acquired and surface virions (positive for GFP and B5) were counted manually. Values represent means of
a minimum of 12 cells per sample with error bars representing SEM. For (a) and (b), egress levels of samples DF12rev, DF12WEWD,
DF12YdF and DF12dm were compared by one-way ANOVA and found to not be significantly different (NS), nor did they differ signifi-
cantly from DF12 or DA36DF12. The difference between rev and YdF was tested by Student’s t-test and found not to be statistically dif-
ferent, nor did WEWD differ significantly from dm. (c) Immunofluorescence of BS-C-1 cells infected with vA5GFP and stained for
surface B5 8 h p.i. ±IMCBH. Bars, 20 µm.
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Fig. 6. Immunofluorescence analysis of infected cells. BS-C-1 cells infected with the indicated viruses at 5 p.f.u. per cell were fixed 8
h p.i. and stained for the presence of A36 and filamentous actin. (a) The A36 staining (red) and GFP signals (green) are shown as
monochrome images and as an RGB (red-green-blue) merge together with DAPI (blue). The F-actin signal is represented as a separate
monochrome image. All images are maximum intensity projections of a z-stack encompassing the full volume of the cell imaged and
are represented at the same magnification. Bar, 20 µm. (b) The boxed regions in (a) are presented as a single optical section at a
higher magnification to show A36 (red) and A5GFP (green) co-localization and F-actin (cyan) showing presence or absence of actin
tails. Bars, 5 µm. The absence of actin tails was confirmed for the YdF and dm mutants after looking at 75 infected cells for
each virus.
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In the absence of A36, some IEV egress on MTs still occurs
[44]. Yet A36 is the only VACV protein known to form a direct
link between IEVs and kinesin-1 [31]. This suggests that
another link between IEVs and kinesin-1 exists, yet none of the
other viral IEV-associated proteins tested interacts with kinesin
[31]. The membranes that form the IEV envelopes contain cel-
lular proteins [56], and being of endosomal or trans-Golgi ori-
gin, it is likely that some of these proteins can recruit motor
proteins, including kinesin-1 [57]. Any protein possessing
WE/D motifs can complement the loss of A36-mediated
recruitment of kinesin-1 [35]. Unlike F12, which is conserved
in all known vertebrate poxviruses (Chordopoxvirinae), A36
orthologues are less conserved outside of the orthopoxviruses.
Viruses from several other chordopoxvirus genera, including
the yatapoxviruses (Yaba-like disease virus [58]), avipoxviruses
(fowlpox virus [59]) and leporipoxviruses (myxoma virus [60])
have been reported to induce actin tails. In some cases, A36
orthologues capable of inducing actin tails were identified
despite low sequence identity (9–14%) [61]. Putative WE/D
motifs were identified in these non-orthopoxvirus A36 ortho-
logues [61], but their ability to recruit kinesin-1 remains to
be tested.
F12, as part of the F12/E2 complex [28], can interact with
KLC in the absence of A36 [43]. This interaction may
induce an allosteric shift that primes the kinesin-1 complex
for binding to other cargo proteins (such as A36) or for
activating its motor activity. VACV and other poxviruses
are therefore flexible in the mediator they use to link IEVs
to kinesin-1. However, in the absence of a functional F12/
E2 complex this does not lead to virus egress. That F12 can
contribute to egress in the absence of A36 is clear, both
from data presented here and from past observations. F12
A36 A5GFP F-ActinA5GFP A36 DAPI
∆ F12rev
∆F12WEWD
∆F12YdF
∆F12dm
(i)
(ii)
(iii)
(iv)
Fig. 7. Immunofluorescence analysis of cells infected with viruses lacking F12. BS-C-1 cells infected with the indicated viruses and
processed as in Fig. 6(a). Bar, 20 µm.
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lacking a region that has been mapped as being involved in
its interaction with A36 does not associate with IEVs [42].
It is unclear however if this mutant F12 is still functional in
other respects. Both F12 and E2 require the other to be
present to associate with IEVs [28]. Whether full-length
F12 or E2 can associate with IEVs in the absence of A36
remains to be determined.
In summary, a mutant virus lacking both F12 and A36
forms a smaller plaque than viruses lacking either protein
alone, showing non-redundant properties. The ability of the
A36 protein to bind kinesin-1 and nucleate actin tails both
contribute to virus spread when protein F12 is present, but
in the absence of the F12 protein whether or not A36 can
bind KLC makes no difference to egress and spread, show-
ing reliance on the F12 protein.
METHODS
Cells
RK-13 cells (rabbit kidney cell line, ATCC CCL-37) were
maintained in minimal essential medium (Gibco) supple-
mented with 10% foetal bovine serum (FBS) and penicillin-
streptomycin (Pen/Strep, Gibco). HeLa cells (human cervix
adenocarcinoma, ATCC CCL-2) were maintained in mini-
mal essential medium supplemented with 10% FBS, and
non-essential amino acids and Pen/Strep (Gibco 11140).
HEK 293T (human embryonic kidney cell line, ATCC CRL-
11268), U-2 OS (human osteosarcoma cell line, ATCC
HTB-96), CV-1 (African green monkey cell line, ATCC
CCL70) and BS-C-1 (African green monkey cell line, ATCC
CCL-26) cell lines were maintained in Dulbecco’s modified
Eagle medium (Gibco) supplemented with 10% FBS and
Pen/Strep.
Construction of recombinant viruses
All viruses used in this study expressed the A5-GFP fusion
protein, which was introduced into a WT VACV Western
Reserve strain [5] and its DF12 and DA36 mutants [44]. A
vDF12 was constructed by introducing a 1207 bp internal
deletion [26] but for the purposes of this study another
vDF12 was constructed that deleted more of the F12 ORF. A
BamHI fragment was subcloned from pDF12 [26] into the
BamHI site of pUC13-EcoGPT-mCherry [43]. A DNA frag-
ment encompassing the last 43 bp of the F12L ORF and
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Fig. 8. Schematic summary of recombinant mutant virus
phenotypes. Schematic representation of the relative efficiency of
virus egress and spread events in the different mutant viruses ana-
lysed. Virus replication and assembly takes place in cytoplasmic struc-
tures referred to as viral factories (F) leading to the formation of IMVs.
Some IMVs (green virions) migrate away from the viral factories and
are wrapped to become IEVs (yellow virions), which are transported to
the cell periphery. Virions on the cell surface (CEVs) can induce the
formation of actin tails. In cells infected by viruses with a WT genotype
(including vA5GFP and vA36rev-A5GFP) levels of egress are normal
and virions at the cell surface can form actin tails (a). Viruses lacking
A36 have a reduced efficiency of virion egress, resulting in some viri-
ons accumulating at the site of wrapping, and those virions that do
make it to the cell surface are unable to form actin tails (b). Restoring
A36 expression with a mutant unable to bind to KLC (vA36WEWD-
A5GFP) restores the ability to form actin tails but not normal levels of
virus egress (c). If A36 expression is restored with a mutant unable to
nucleate actin polymerization, virion egress is restored to levels simi-
lar to viruses expressing WT A36, but no actin tails are formed (d).
Viruses expressing A36 in which both functions have been mutated
show egress levels similar to A36WEWD-expressing viruses but are
unable to form actin tails (e). Viruses lacking F12 have drastically
reduced IEV egress, resulting in accumulation of IEVs at the site of
wrapping; however, those virions that reach the cell surface are able
to form actin tails (f). Disrupting A36 expression in these viruses does
not alter the level of IEV egress but prevents actin tail formation,
resulting in the plaque size reduction described in Fig. 1(g). All of the
mutant A36-expressing viruses in which F12 expression has been dis-
rupted show egress levels identical to WT A36-expressing viruses,
irrespective of whether A36 can interact with KLC. Introducing an A36
that can induce actin polymerization (h) rescues plaque size slightly
(though to levels below that of WT A36-expressing viruses). Those
viruses unable to form actin tails produce plaque sizes slightly
smaller than viruses that lack A36 altogether (Fig. 4) irrespective of
whether A36 can (i) or cannot (j) interact with KLC unlike for the
viruses expressing F12 where the ability of A36 to bind KLC leads to
enhanced plaque size (Fig. 3). N, Nucleus.
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365 bp downstream from VACV WR was generated by PCR
using oligonucleotides F12-DnStrF1 (5¢-CACCCCCGGG
TAAAGATATTAATGAA-TCCATGAGTCAGATG-3¢) and
F12-DnStrR1 (5¢-CACCGAATTCCAGCATCTAACTTGA
TGTCAGG-3¢) and cloned into the XmaI-EcoRI sites of the
same plasmid to generate pEcoGPT-mCherry-DF12 mkII.
This plasmid was used to generate the vDA36DF12-A5GFP
virus by transient dominant selection [62, 63]. Briefly, CV-1
cells were transfected with the plasmid and infected with the
parent virus. Recombinant viruses that incorporated the plas-
mid by recombination and expressed the EcoGPT-mCherry
fusion protein were selected by serial passage and plaque
purification on monolayers of BS-C-1 cells under selection by
mycophenolic acid supplemented with hypoxanthine and
xanthine. After isolation of an intermediate clone, the virus
was plaque purified three additional times without selection
to isolate clones that had undergone a second recombination
event and lost expression of EcoGPT-mCherry. Viruses that
had incorporated the new DF12 mkII allele were differenti-
ated from those that had reverted to a parental genotype by
PCR and sequence analysis. The virus lacking both F12 and
A36 (double deletion virus) was constructed by using vDA36-
A5GFP as parental virus. In parallel, the DF12 mkII allele was
used to replace the DF12 allele in vDF12-A5GFP to generate
viruses with identical deletions at the F12 locus. Analysis of
this new vDF12, used for the rest of this study, confirmed it
had the same phenotype as the original parental virus.
The pEcoGPT-mCherry-A36rev plasmid was generated by
amplifying the A36 locus by PCR, including about 350 bp
upstream and downstream of the ORF, using oligonucleotides
A36 UP F (5¢-GATCAAGCTTTGGCTAGATTCAACATT
TATAGCATTTGTG-3¢) and A36 DN R (5¢-GA-TCGAATT
CACGACACATTTACTCAGTGGGGATATG-3¢) and clon-
ing the product into the HindIII-EcoRI sites of pUC13-
EcoGPT-mCherry. The pEcoGPT-mCherry-A36YdF plasmid
was generated by amplifying two DNA fragments by PCR
using VACV WR genomic DNA template and oligonucleoti-
des A36 UP F with A36YdF R (5¢-ACTGTAG-TGTTC
TGAAAAATAGTCTGTTCATTACGATCATTATTTATTA
GCAGCGTGCTTCCAGCAACACTATCGAA-3¢), and A36
DN R with A36YdF F (5¢-AGCACAGAACACATTTTCGA
TAGTGTTGCTGGAAGCACGCTGC-TAATAAATAATG
ATCGTAATGAACAGACTATTTTTC-3¢). The two frag-
ments incorporating the YdF mutations were spliced by over-
lap extension and inserted into the HindIII-EcoRI sites
of pUC13-EcoGPT-mCherry. The pEcoGPT-mCherry-
A36WEWD and pEcoGPT-mCherry-A36dm plasmids were
generated by splicing two DNA fragments generated by PCR
using pEcoGPT-mCherry-A36rev as template and oligonu-
cleotides A36atgKpnIF (5¢-ATGATGCTGGTACCTCTTA
TCAC-3¢) with A36NarI-WD/AA R (5¢-GATGGGCGCCA
TGACATTGGATTCG-TTAGCCGCTATTAAACTACC-3¢)
and A36-WE/AA SOE F (5¢-TCAGACGCTGCAGATCAC
TGTAGTGCTATGGAAC-3¢) with A36-WE/AA SOE R (5¢-
GTGATC-TGCAGCGTCTGATTCGCTATCAGTTGATTT
AC-3¢) and inserting the product into pEcoGPT-mCherry-
A36rev and pEcoGPT-mCherry-A36YdF, respectively.
These plasmids were all used to generate recombinant
viruses as described above using vDA36-A5GFP as the
parental virus to generate recombinants expressing both
F12 and a mutant form of A36, and vDA36DF12-A5GFP as
the parental virus to generate recombinants expressing the
mutant A36 proteins but lacking F12 expression.
Viruses were analysed by PCR to identify recombinants.
PCRs were used to distinguish the WT F12 and DF12 alleles
(oligonucleotides F12RevDC1 5¢-CATCTTTGATCTCGA-
TGGAATGCA-3¢ with F12ForDC1 5¢-ATGTTAAACA-
GGGTACAAATCTTGATGA-3¢), the presence or absence
of the EcoGPT cassette (oligonucleotides EcogptDCF1 5¢-
CGTCACCTGGGACATGTTG-3¢ with EcogptDCR1 5¢-
GACGAATACGACGCCCATAT C-3¢), the full length and
DA36 alleles [oligonucleotides A36 UP F see above (green
arrow in Fig. 2a) with DCA36seqR1 5¢-ACCGTTTCAT-
CCATCTGTCTATTG-3¢ (blue arrow in Fig. 2a)], and the
full length A36 using oligonucleotide A36deltestF (5¢-
CTTA-TCACGGTGACCGTAG-3¢, red arrow in Fig. 2a)
with DCA36seqR1. To verify that the correct A36 mutations
had been incorporated into the final recombinant viruses
PCR fragments were sequenced.
Plaque size analysis
Monolayers of BS-C-1 cells in six-well plates were infected
with 20–30 p.f.u. per well. Plaques were left to develop for
the indicated time under a semi-solid overlay containing
1.5% carboxymethyl-cellulose. Plaques were either stained
with crystal violet or fixed with 4% paraformaldehyde in
PBS for 30 min at room temperature. Plaques stained with
crystal violet or GFP-positive plaques were imaged using an
Axio Observer.Z1 inverted microscope. Historically we have
estimated plaque size by drawing a circle around it, using
tools available in the AxioVision (Zeiss) imaging software
package, and determining the radius. Plaques are however
not perfect circles. In our experience this approach is sensi-
tive enough to detect moderate to large plaque size changes
but fails to detect small changes in plaque size. During this
study we shifted from measuring plaque radius to the more
accurate approach of measuring the exact surface area of
individual plaques using the spline selection tool available
in AxioVision (release 4.8). While initial measurements
comparing vDA36, vDF12 and vDA36DF12 were done using
the original method (Fig. 1), measurements for these viruses
were repeated using surface area measurements (Figs 3 and
4). For each sample, a minimum of 15 measurements from
three independent wells (for a total of 45 measurements)
were used to carry out statistical analysis using the statistical
software package GraphPad Prism (version 5.04).
Immunofluorescence microscopy
BS-C-1 cells were seeded onto poly-D-lysine-coated glass
coverslips (19mm diameter, thickness no.1) in 12-well
plates and left to attach for a minimum of 36 h prior to
infection. Cells were infected with 5–10 p.f.u. per cell and
fixed 8 h post-infection (p.i.) with 4% paraformaldehyde in
250mM HEPES pH 7.5 for 30 min on ice followed by 8%
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paraformaldehyde in 250mM HEPES pH 7.5 for 15 min at
room temperature.
Fixed cells were blocked with 10% FBS and 5% goat serum
(D9663; Sigma) in PBS and permeabilized with 0.1% Triton
X-100. Cells were stained with anti-A36 mouse monoclonal
antibody [23], Alexa Fluor 546-conjugated donkey anti-
mouse secondary antibodies (Life Technologies) and Alexa
Fluor 647-conjugated phalloidin. Cells were mounted [10%
(w/v) Mowiol 4-88 (CalBiochem), 25% (v/v) glycerol,
100mM Tris-HCl pH 8.5, 0.5 µg ml 1 DAPI (4¢,6-diami-
dino-2-phenylindole; Sigma)] and imaged using a Zeiss
LSM780 confocal laser scanning microscopy system
mounted on an AxioObserver.Z1 inverted microscope using
a 64 Plan Apochromat objective (numerical aperture 1.4)
and Zen (Zeiss, 2011 version) acquisition software. z-Stacks
encompassing the full volume of the cell were acquired and
used to generate maximum fluorescence intensity projec-
tions down the z-axis. Images were processed and analysed
using Zen, ImageJ and Photoshop (Adobe) software.
IEV egress assay
For flow cytometric analysis of surface B5 levels, BS-C-1,
HeLa or U-2 OS cells were seeded into 24-well plates and
left to settle for at least 36 h prior to infection. Cells were
infected at 10 p.f.u. per cell. At 12–16 h p.i., cells were
placed on ice and stained for B5 as previously described
[43]. Fluorescence was measured using a Becton Dickinson
Cytek FACScan DxP8 and analysed using MoFlo software.
Statistical analysis of triplicate samples was carried out using
GraphPad Prism statistical analysis software.
For analysis of virus egress by immunofluorescence, BS-C-1
cells were seeded onto poly-D-lysine-coated coverslips and
infected as described above. At 8 h p.i., cells were placed on
ice and stained for B5 as for flow cytometric analysis except
that cells were fixed after the primary antibody as described
above and stained with an Alexa Fluor 647 goat anti-rat sec-
ondary antibody (Life Technologies). The cells were imaged
as described above and surface B5-positive, GFP-positive
virions were counted manually using ImageJ software.
The drug N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoyl-
hydrazine (IMCBH) was used in several of our assays as an
inhibitor of VACV wrapping. IMCBH was provided by R.
Wittek from the University of Lausanne (Lausanne,
Switzerland). IMCBH was used at a final concentration of
5 µgml 1.
Co-immunoprecipitation and immunoblot protein
analysis
Co-immunoprecipitation analysis was carried out as
described [43]. Briefly, cells in 10 cm diameter dishes were
transfected with Flag-KLC1- or Flag-GFP- expressing plas-
mids using transit-LT1 transfection reagent (Mirius) and
24–36 h later were infected at 5 p.f.u. per cell for 14 h. Cells
were then lysed in IP wash buffer [50mM Tris-HCl pH 7.5,
0.5% (v/v) Nonidet P40 substitute (Sigma), 150mM NaCl,
2mM EDTA] supplemented with complete Mini EDTA-
free protease inhibitor cocktail tablets (Roche), on ice for
45min with occasional vortexing. Lysates were clarified by
centrifugation (15 000 g, 15min, 4

C) and Flag-tagged pro-
teins were immunoprecipitated using anti-FLAG M2 affin-
ity gel (Sigma). Immunoprecipitations were incubated with
rotation overnight and then washed four times with IP wash
buffer. Immunoprecipitated proteins were eluted by boiling
in Laemmli loading buffer and analysed by SDS-PAGE
and immunoblotting.
Proteins separated by SDS-PAGE and transferred onto
Hybond ECL nitrocellulose membrane (GE Healthcare)
were probed with rabbit polyclonal aFLAG (F7425; Sigma-
Aldrich, 1 : 5 000), mouse monoclonal aA36 [23] and mouse
monoclonal AB1.1 specific for the VACV protein D8 [22].
Blots were probed with IRDye-conjugated secondary anti-
bodies (LI-COR), and imaged using a LI-COR Odyssey
scanner. Detection of the A36 protein, which has a similar
molecular mass to the antibody heavy chain, was achieved
by using a Biotin-SP AffiniPure goat anti-mouse IgG, light
chain specific (115-065-174; Jackson ImmunoResearch).
Biotinylated secondary antibodies were visualized using
IRDye-conjugated streptavidin (LI-COR).
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